MainlyAI in Innovation Milieu ASSET

MainlyAI has, together with Diamyd Medical, Leading Health Care, Lund University, National Diabetes Register, and Sahlgrenska University Hospital, been granted funding by the Swedish governmental funding agency, VINNOVA, in the Innovation milieus in precision health 2021 call. The project, named AI for Sustainable Prevention of Autoimmunity in the Society (ASSET) will run over five yearsContinue reading “MainlyAI in Innovation Milieu ASSET”

MainlyAI in Production and Logistics project EXPLAIN

MainlyAI has, together with AstraZeneca, Hitachi-ABB, KTH, RISE IVF, Scania-CV, SECO Tools, and Uppsala University, been granted funding by the Swedish governmental funding agency, VINNOVA, in the Production 2030 call. The project, named Explainable and Learning production & logistics by Artificial Intelligence (EXPLAIN) will run over three years with a total budget of 13 MSEK.Continue reading “MainlyAI in Production and Logistics project EXPLAIN”

MainlyAI awarded VINNOVA funding in the Innovative Startup program

Today, MainlyAI AB was awarded funding by the Swedish Governmental Innovation Agency VINNOVA. In the project, MainlyAI will continue to develop its AI-solutions for safely sharing machine readable knowledge between businesses. With this funding, MainlyAI will be able to take important and necessary steps towards market introduction of our products and services for creating valueContinue reading “MainlyAI awarded VINNOVA funding in the Innovative Startup program”

MainlyAI continues to strengthen its development team: meet Kristofer Älvring

1.    What are you looking forward to the most when starting at MainlyAI?             If you’re going to build algorithms, which will change the world, you need a swift, smart and fierce crew skilled in navigating stormy seas, capturing whales and dodging sharks, all whilst having great fun at the same time. I feel reallyContinue reading “MainlyAI continues to strengthen its development team: meet Kristofer Älvring”

Diamyd Medical invests in MainlyAI

Diamyd Medical’s investment will give a 20% ownership and a board seat in MainlyAI. The investment will facilitate MainlyAI’s strategic focus on applying artificial intelligence, where a first project is sustainable production within the pharmaceutical sector. As announced in  December 2020, Diamyd Medical and MainlyAI are, together with the Royal Institute of Technology (KTH), engagedContinue reading “Diamyd Medical invests in MainlyAI”

MainlyAI awarded VINNOVA funding for AI-driven sustainable production

MainlyAI AB together with Diamyd Medical and KTH Royal Institute of Technology have been awarded funding by the Swedish Governmental Innovation Agency VINNOVA for a project that will design, test and build a sustainability framework powered by artificial intelligence (AI) for Diamyd Medical’s production facility in Umeå, Sweden. The project ALISTAIR (Artificial Intelligence for SustainableContinue reading “MainlyAI awarded VINNOVA funding for AI-driven sustainable production”